Vol 58, No 2 (2007)
Review paper
Published online: 2007-03-13

open access

Page views 636
Article views/downloads 4547
Get Citation

Connect on Social Media

Connect on Social Media

Glucocorticoid-induced osteoporosis

Wanda Foltyn, Beata Kos-Kudła, Bogdan Marek, Dariusz Kajdaniuk, Joanna Głogowska-Szeląg, Lucyna Siemińska, Janusz Strzelczyk, Małgorzata Borowska
Endokrynol Pol 2007;58(2):170-176.

Abstract

Prolonged glucocorticoids administration is the most common cause of secondary osteoporosis. It is estimated that 30% to 50% of chronic glucocorticoids users experience vertebral or hip fractures. The highest bone loss (up to 30% in some studies) is observed in the first six months of treatment. Only a minority of patients who take chronic glucocorticoids receive optimal osteoporosis diagnosis, prevention, and/or treatment. The aim of this paper is to present the pathophysiology of glucocorticoid-induced osteoporosis, as well as some guidelines on diagnostic, preventive and therapeutic strategies for this disorder in an effort to promote the greater awareness of it.

Article available in PDF format

View PDF (Polish) Download PDF file